GCA
CC icon

Gideon Capital Advisors’s Chemours CC Stock Holding History

Gideon Capital Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,277
Closed -$828K – 290
2019
Q1 		$828K Buy
+22,277
New +$811K 0.3% 87
2018
Q3 		– Sell
-4,719
Closed -$209K – 358
2018
Q2 		$209K Buy
+4,719
New +$235K 0.1% 336
2017
Q4 		– Sell
-4,142
Closed -$210K – 304
2017
Q3 		$210K Buy
+4,142
New +$195K 0.21% 248
2017
Q1 		– Sell
-14,340
Closed -$317K – 405
2016
Q4 		$317K Buy
+14,340
New +$294K 0.2% 233

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gideon Capital Advisors's CC Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Chemours (CC) in Q2 2019, closing a stake of 22,277 shares — an estimated $828K sold.

Gideon Capital Advisors first reported a position in CC in Q4 2016 and held it in 4 quarters. The position peaked at $828K in Q1 2019. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Gideon Capital Advisors reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 22,277 Chemours shares in Q2 2019, an estimated $828K.
  • Gideon Capital Advisors first reported a position in Chemours in Q4 2016 and held it in 4 quarters.
  • Gideon Capital Advisors's Chemours position peaked at $828K in Q1 2019.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.